

Evrysdi, Spinraza or Zolgensma Denial
Have You Been Denied Evrysdi (formerly Risdiplam), Spinraza or Zolgensma to treat Spinal Muscular Atrophy (SMA)?
If the answer is yes, we can help. Call now or fill out the Free Consultation form on this page.
Spinal Muscular Atrophy is a genetic degenerative disease that impacts the motor nerve cells in the spinal cord. People who have this disease can lose their ability to breathe, eat and walk. There are three FDA approved medications to treat SMA including Spinraza, Zolgensma, and now Evrysidi (formerly Risdiplam).
But some insurance providers deny these treatments because they are expensive. Has someone in your family been denied Evrysidi, Spinraza or Zolgensma by one of the following insurance companies:
- Anthem Blue Cross,
- Blue Shield,
- Health Net,
- Kaiser,
- UnitedHealthcare,
- Aetna, or
- another insurance company?
The Law Offices of Scott Glovsky can help you.
Los Angeles and California health insurance denial attorney Scott Glovsky helps members seek justice for medically necessary denials. Please call our office or fill out the Free Consultation form on this page.

Meet Our Team
If Results Matter, Then Hire Us

Our Case Results
Relentlessly Tough, Relentlessly Personal
Scott began representing policyholders instead of insurance companies in 1999 and has consistently sought justice for his clients in ways other firms cannot. Scott is passionate about helping policyholders obtain treatments, coverage, and reimbursement from California insurance companies, including Aetna, Anthem Blue Cross, Blue Shield of California, Health Net, Kaiser Permanente UnitedHealthcare, and other companies providing insurance.
-
$17.3 Million
Wrongful death personal injury case.
-
$17.3 Million
I enjoy getting families the justice and compensation they deserve.
-
$14.9 Million
I’m happiest when I’m fighting for justice against big companies that think they’re untouchable.
-
$10 Million
General areas addressed: health insurance; treatment and procedure coverage; physician recommendations; critical organ, brain, cancer or spinal cord issues; and out of network coverage issues.
-
$9.29 Million
Arce v. Kaiser. Kaiser Permanente sued for denying ABA and speech therapy to children with Autism Spectrum Disorders.
